未登录

Z

Zhiheng Xu

fudan university

H指数:9

被引数:272

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GLP-1 Receptor Agonist Semaglutide Ameliorates Motor Deficits and Tau Pathology in the rTg4510s Mouse Model

GLP-1受体激动剂Semaglutide改善了rTg4510s小鼠模型中的运动缺陷和Tau病理。

Neuropharmacology

IF4.6

2025-08-270

PRE

Evaluating the Clinical Utility of a Machine Learning Model for Diagnosing Parkinson’s Disease Using Acoustic Parameters

评估基于声学参数的机器学习模型在帕金森病诊断中的临床应用价值

Journal of Voice

IF2.4

2025-06-170

PRE

Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson's disease subtypes

血浆GFAP和NfL与假定的脑先型和体先型帕金森病亚型的脑葡萄糖代谢相关

NPJ PARKINSONS DISEASE

IF8.2

2025-03-221

OA

Association of plasma homocysteine with cognitive impairment in patients with Parkinson's disease

帕金森病患者血浆同型半胱氨酸水平与认知功能障碍的关系

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2024-12-090

OAAI

Using a smartphone-based self-management platform to study sex differences in Parkinson's disease: multicenter, cross-sectional pilot study

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2024-06-210

OAAI

Disease progression in proposed brain-first and body-first Parkinson's disease subtypes

NPJ PARKINSONS DISEASE

IF8.2

2024-06-040

OAAI

Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia

NPJ PARKINSONS DISEASE

IF8.2

2023-02-0926

OAAI

In Vivo 18F-Florzolotau Tau Positron Emission Tomography Imaging in Parkinson's Disease Dementia

MOVEMENT DISORDERS

IF7.6

2022-11-1114

PRE

Deep Clinical Phenotyping of Parkinson's Disease: Towards a New Era of Research and Clinical Care

帕金森氏病的深度临床表型: 迈向研究和临床护理的新时代

IF6.2

2022-05-219

OA

Determinants of quality of life in Parkinson's disease: a perspective of novel clinical subtypes

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

IF3.9

2021-10-303

OA

Disease progression in Parkinson's disease patients with subjective cognitive complaint

以主观认知为主诉的帕金森病患者的疾病进展

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

IF3.9

2021-09-3013

OA

TGF-β1 inhibits the autophagy of podocytes by activating mTORC1 in IgA nephropathy

EXPERIMENTAL CELL RESEARCH

IF3.5

2019-12-0116

PREAI

DOES THE ADDITION OF INVOLVED FIELD RADIOTHERAPY TO HIGH-DOSE CHEMOTHERAPY AND STEM CELL TRANSPLANTATION IMPROVE OUTCOMES FOR PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA?

对于复发/难治性霍奇金淋巴瘤患者，在大剂量化疗和干细胞移植的基础上增加相关野放疗是否能改善预后？

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2011-09-0134

PREAI